Orthopedic Medication Reconciliation: Clinical Relevance, Challenges, and Best Practices

Abstract

Medication reconciliation in orthopedic medicine is a critical component of patient safety, aiming to prevent adverse drug events and optimize clinical outcomes. With the increasing complexity of pharmacotherapy, especially in elderly and multi-morbid patients, the accuracy of medication histories and interdisciplinary communication are paramount. This review provides a comprehensive examination of the epidemiology, pathophysiology, risk factors, clinical features, diagnostic considerations, management strategies, recent advances, and current guideline recommendations relevant to medication reconciliation in orthopedic practice. The article synthesizes recent evidence and offers practical insights for implementation in clinical settings.

Introduction

Medication reconciliation is a systematic process to ensure that patients’ medication lists are accurate and complete across transitions of care. In orthopedic settings, where polypharmacy is prevalent due to comorbidities such as osteoporosis, cardiovascular disease, and chronic pain, reconciliation is crucial for preventing medication errors, interactions, and adverse events. Orthopedic patients often undergo surgical interventions and perioperative changes in therapy, increasing the risk of miscommunication and iatrogenic harm. This article aims to elucidate the essential aspects of medication reconciliation in orthopedic practice, emphasizing clinical implications, evidence-based strategies, and emerging trends.

Epidemiology / Disease Burden

Medication discrepancies are common in hospitalized patients, with studies estimating rates as high as 60% among orthopedic admissions. The elderly, who constitute a substantial proportion of orthopedic caseloads, are particularly vulnerable due to polypharmacy and cognitive impairment. A 2022 multicenter observational study found that orthopedic wards reported higher rates of medication discrepancies compared to general medical wards, primarily due to complex perioperative medication adjustments. Adverse drug events (ADEs) contribute significantly to morbidity, prolonged hospital stays, and increased healthcare costs in orthopedic populations, underscoring the importance of robust reconciliation protocols.

Pathophysiology

The pathophysiological basis for medication errors in orthopedics centers on pharmacokinetic and pharmacodynamic changes associated with surgical stress, immobilization, and altered organ function. Perioperative periods often necessitate modifications in anticoagulation, analgesia, and antimicrobial prophylaxis. Inadequate reconciliation may lead to unintended discontinuation or duplication of therapy, drug-drug interactions, or inappropriate dosing, particularly in patients with renal or hepatic impairment. Additionally, orthopedic trauma and surgery can alter drug absorption, distribution, and elimination, further complicating medication management.

Risk Factors

Several risk factors predispose orthopedic patients to medication discrepancies. These include advanced age, cognitive impairment, multiple comorbidities, polypharmacy (use of five or more medications), frequent transitions of care (e.g., admission, transfer, discharge), lack of standardized communication tools, and limited integration of electronic health records. High-risk medications in orthopedics include anticoagulants, opioids, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying agents. Socioeconomic factors and inadequate patient education further compound the risk.

Clinical Features

Clinical manifestations of medication errors in orthopedic patients range from subtle laboratory abnormalities to severe outcomes such as bleeding, thromboembolic events, delirium, renal dysfunction, and uncontrolled pain. Unrecognized discrepancies may present as postoperative complications, delayed wound healing, or exacerbation of underlying comorbidities. In some cases, the first indication of a reconciliation error may be an unexpected clinical deterioration, necessitating high clinical vigilance and routine medication review.

Diagnosis

Diagnosis of medication discrepancies relies on a thorough and systematic approach. The gold standard involves obtaining the best possible medication history (BPMH), which includes patient interviews, review of prescription records, consultation with outpatient providers, and verification with family or caregivers. Structured reconciliation forms and checklists are recommended to standardize data collection. Discrepancies should be categorized as intentional (clinically justified changes) or unintentional (errors) to guide targeted interventions. Collaboration between physicians, pharmacists, and nursing staff is essential for accurate diagnosis and resolution.

Treatment & Management

Effective management of medication reconciliation involves multidisciplinary engagement and structured processes. Key steps include: 1) compiling an accurate pre-admission medication list; 2) comparing with current orders upon admission, transfer, and discharge; 3) resolving discrepancies through direct communication and clinical judgment; and 4) documenting changes and rationales. Pharmacist-led interventions have demonstrated significant reductions in medication errors and ADEs in orthopedic settings. Patient education and clear discharge instructions are vital for continuity of care. Technology, such as integrated electronic health records and clinical decision support systems, can augment reconciliation efforts.

Recent Advances / Emerging Therapies

Recent advances focus on leveraging health information technology to streamline medication reconciliation. Automated alert systems, mobile apps for medication tracking, and real-time data sharing across healthcare systems are being implemented to minimize errors. Artificial intelligence-driven tools are under investigation for predictive risk stratification and identification of high-risk patients. Furthermore, telemedicine has emerged as a valuable adjunct for post-discharge follow-up and ongoing medication review. Research supports the integration of pharmacist practitioners within orthopedic teams to enhance reconciliation quality and patient outcomes.

Guideline Recommendations

Current guidelines from organizations such as the Joint Commission, American Academy of Orthopaedic Surgeons (AAOS), and the Institute for Safe Medication Practices (ISMP) emphasize medication reconciliation as a standard of care. Recommendations include conducting reconciliation at every transition of care, involving patients and families in the process, utilizing standardized forms and workflows, and prioritizing high-risk medications. Continuous quality improvement initiatives and staff education are advocated to sustain best practices. Guidelines further recommend periodic audits and feedback to monitor reconciliation accuracy and clinical impact.

Conclusion

Medication reconciliation is an indispensable component of orthopedic practice, directly influencing patient safety, clinical outcomes, and healthcare resource utilization. Despite challenges posed by patient complexity and system-level barriers, evidence-based strategies and technological innovations have demonstrated efficacy in reducing medication discrepancies and adverse events. Adherence to established guidelines, multidisciplinary collaboration, and ongoing education are critical for optimizing reconciliation processes. As orthopedic care continues to evolve, ongoing research and quality improvement will remain essential to enhance medication safety and patient-centered outcomes.